Related Experiment Video
Updated: Aug 6, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Prevalence and risk of cardiovascular events among people living with HIV: a meta-analysis
Shuqing Jin1,2, Hongfei Liu3, Xiyuan Song1
1AIDS Clinical Research Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Henan, China.
Insights
People living with HIV face significant cardiovascular risks from both traditional and HIV-specific factors. Prioritizing early risk assessment, viral suppression, and immune recovery is crucial for managing these events in this population.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- People living with HIV (PLWH) exhibit elevated cardiovascular disease (CVD) risk.
- The specific contribution of HIV-related factors to overall CVD events remains incompletely understood.
- This study aimed to clarify the prevalence and determinants of cardiovascular events in PLWH.
Purpose of the Study:
- To determine the prevalence of cardiovascular events in people living with HIV (PLWH).
- To identify traditional and HIV-specific risk factors associated with cardiovascular events in PLWH.
- To explore subtype-specific risk profiles for different cardiovascular events.
Main Methods:
- A systematic review and meta-analysis of observational studies was conducted.
- Studies were identified through comprehensive searches of major biomedical databases (PubMed, EMBASE, Cochrane, Web of Science, Scopus) from 2004 to 2024.
- Pooled relative risks and prevalence were calculated, with heterogeneity assessed using standard statistical methods.
Main Results:
- Analysis of 43 studies involving over 4 million PLWH revealed a 6% prevalence of cardiovascular events.
- Key risk factors included older age, smoking, antiretroviral therapy, male sex, low CD4+ T-cell count, detectable viral load, dyslipidemia, hypertension, diabetes, syphilis, prior CVD, and elevated red cell distribution width.
- Higher CD4+ counts and Hispanic ethnicity were associated with reduced risk, while specific factors like smoking, ART, and dyslipidemia were linked to myocardial infarction; prior CVD and low CD4+ to arrhythmias; and male sex, dyslipidemia, hypertension, and syphilis to stroke.
Conclusions:
- PLWH experience a considerable burden of cardiovascular events, influenced by both conventional and HIV-specific risk factors.
- Implementing early cardiovascular risk assessment is essential for this population.
- Strategies focusing on viral suppression and immunological recovery are critical for mitigating cardiovascular risk in PLWH.
Background:
People living with HIV (PLWH) have increased cardiovascular risk, but the contribution of HIV-related factors to all-cause cardiovascular events remains unclear. We assessed the prevalence and determinants of cardiovascular events in PLWH, including subtype-specific risk profiles.
Methods:
PubMed, EMBASE, Cochrane Library, Web of Science and Scopus were searched from January 1, 2004 to October 31, 2024. Observational studies reporting cardiovascular event prevalence or adjusted risk estimates in PLWH were included. Two reviewers independently selected studies and extracted data. Pooled relative risks (RRs) and 95% confidence intervals (CIs) were calculated using fixed- or random-effects models, and heterogeneity was assessed using Cochran's Q and I2 statistics.
Results:
Forty-three studies including 4,175,459 PLWH and 166,225 cardiovascular events were analyzed. The pooled prevalence of cardiovascular events was 6% (95% CI: 0.05-0.07). Higher risk was associated with older age, smoking, antiretroviral therapy, male sex, CD4+ T-cell count <200 cells/mm3, detectable HIV viral load, dyslipidemia, hypertension, diabetes, syphilis coinfection, prior cardiovascular disease and elevated red cell distribution width. Higher CD4+ counts (per 100 cells/mm3) and Hispanic ethnicity were associated with lower risk. Subgroup analyses showed that smoking, antiretroviral therapy and dyslipidemia were linked to myocardial infarction; prior cardiovascular disease and CD4+ T-cell count <200 cells/mm3 to arrhythmia; and male sex, dyslipidemia, hypertension and syphilis coinfection to stroke.
Conclusion:
PLWH have a substantial cardiovascular event burden driven by both traditional and HIV-related risk factors. Early cardiovascular risk assessment, viral suppression and immunological recovery should be prioritized.
More Related Videos
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
Related Concept Videos
Retrovirus Life Cycles
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Coronary Artery Disease IV: Preventive Measures
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Bias in Epidemiological Studies
Coronary Artery Disease III: Clinical Manifestations